Overview
Employees
51-200
Founded date
1986
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 12, 2023 | French pharma Amolyt nets €130 million series C co-led by Sofinnova Partners | Amolyt Pharma, an Ecully, France-based pharma startup working on rare disease treatments, has closed a €130 million series C round. Amolyt is targeting rare indications affecting the body's hormone supply from endocrine glands. The series C... |
| Oct 18, 2022 | Oculis to go public via SPAC | |
| May 7, 2021 | Oculis closes US$57 million Series C financing | The oversubscribed round was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing investors, Bay City Capital, Brunnur Ventures, EarlyBird, funds managed by Tekla Cap... |
| May 7, 2021 | Oculis closes US$57 million Series C financing | |
| Apr 9, 2021 | Tekla Healthcare Opportunities Fund : Joint Proxy Statement | TEKLA HEALTHCARE INVESTORS TEKLA LIFE SCIENCES INVESTORS TEKLA HEALTHCARE OPPORTUNITIES FUND TEKLA WORLD HEALTHCARE FUND 100 Federal Street, 19th Floor Boston, Massachusetts 02110 (617) 772-8500 NOTICE OF JOINT ANNUAL MEETING OF SHAREHOLDER... |
| Oct 19, 2020 | VectivBio secures $110 million to finance Phase III clinical trials | |
| Oct 19, 2020 | VectivBio secures $110 million to finance Phase III clinical trials | VectivBio closed a $110 million crossover financing from new investors Surveyor Capital (a Citadel company), Cormorant Capital and Eventide Asset Management, with participation from existing investors Versant Ventures, OrbiMed, Novo Holding... |
| Jan 9, 2020 | Therachon spin-off launches with $35 million investment | |
| Jan 9, 2020 | Therachon spin-off launches with $35 million investment | VectivBio, a clinical-stage biotechnology company, is bringing transformational medicines to patients with serious rare diseases. The company announced its formation with $35 million in financing including commitments by Versant Ventures, O... |
Show more
Reviews 0
FAQ about Tekla Capital Management LLC
When was Tekla Capital Management LLC founded?
Tekla Capital Management LLC was founded in 1986.
What has the press written about Tekla Capital Management LLC?
Parsers VC has collected 14 articles mentioning Tekla Capital Management LLC, among them “French pharma Amolyt nets €130 million series C co-led by Sofinnova Partners” (Jan 12, 2023) and “Oculis to go public via SPAC” (Oct 18, 2022).
Is Tekla Capital Management LLC still active?
Yes, Tekla Capital Management LLC is active; its latest activity on Parsers VC dates from Jan 12, 2023.